Uses of enoxaparin to counteract covid-19

The impact of the COVID-19 pandemic has been dramatic worldwide, with many countries now in the midst of the second wave. Researchers and clinicians are studying and testing different approaches to prevent the infection and minimize its severity. Many scientists, researchers, and clinicians are primarily focusing on optimizing mechanical ventilation, antiviral, and supportive treatment.

There is strong evidence indicating that a cytokine storm occurs during the attack of SARS-CoV- 2 infection to a human. A cytokine storm is when various inflammatory cytokines are produced at a much quicker and higher rate than normal. This overproduction of cytokines causes organ damage. The development of cytokine storms results in the necrosis of epithelial cells, increased permeability of vascular cells, and abnormal cellular and humoral immunity, eventually resulting in acute lung injury, acute respiratory distress syndrome (ARDS), and death. Enoxaparin is used to counteract Covid-19 effects, especially cytokine storms. Enoxaparin is an anticoagulant that helps prevent the formation of blood clots. Enoxaparin is used to treat and prevent deep vein thrombosis (DVT). DVT can often lead to blood clots in the lungs (pulmonary embolism). Enoxaparin works by treating this lung-related syndrome in Covid-19 patients.

To know more about the uses of enoxaparin to counteract covid-19 and book a bulkorder, give stanex pharmaceuticals a call or visit our website.